Concepts (357)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 71 | 2024 | 2207 | 12.940 |
Why?
|
| Florida | 69 | 2024 | 358 | 6.480 |
Why?
|
| Residence Characteristics | 22 | 2022 | 301 | 5.560 |
Why?
|
| Anti-HIV Agents | 10 | 2020 | 394 | 5.040 |
Why?
|
| Viral Load | 16 | 2022 | 300 | 3.630 |
Why?
|
| Healthcare Disparities | 10 | 2018 | 446 | 3.220 |
Why?
|
| Emigrants and Immigrants | 10 | 2021 | 125 | 3.080 |
Why?
|
| Continuity of Patient Care | 7 | 2020 | 90 | 2.850 |
Why?
|
| Mass Screening | 13 | 2019 | 427 | 2.790 |
Why?
|
| Homosexuality, Male | 9 | 2022 | 438 | 2.730 |
Why?
|
| Acquired Immunodeficiency Syndrome | 8 | 2024 | 214 | 2.630 |
Why?
|
| Adolescent | 55 | 2022 | 5035 | 2.550 |
Why?
|
| Humans | 127 | 2024 | 34853 | 2.460 |
Why?
|
| Adult | 76 | 2024 | 11034 | 2.340 |
Why?
|
| Female | 91 | 2023 | 19873 | 2.230 |
Why?
|
| Young Adult | 41 | 2022 | 4012 | 1.960 |
Why?
|
| Male | 76 | 2023 | 18870 | 1.930 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2021 | 11 | 1.790 |
Why?
|
| Depression, Postpartum | 3 | 2017 | 10 | 1.780 |
Why?
|
| Poverty | 12 | 2021 | 316 | 1.730 |
Why?
|
| Food Handling | 6 | 2010 | 33 | 1.710 |
Why?
|
| Urban Population | 10 | 2021 | 318 | 1.660 |
Why?
|
| Rural Health | 4 | 2016 | 45 | 1.600 |
Why?
|
| Population Surveillance | 10 | 2019 | 231 | 1.600 |
Why?
|
| United States | 28 | 2024 | 3894 | 1.570 |
Why?
|
| Health Education | 7 | 2019 | 304 | 1.570 |
Why?
|
| Prenatal Care | 4 | 2017 | 74 | 1.550 |
Why?
|
| Anomie | 2 | 2021 | 6 | 1.550 |
Why?
|
| Health Status Disparities | 6 | 2021 | 583 | 1.510 |
Why?
|
| Delayed Diagnosis | 5 | 2017 | 28 | 1.410 |
Why?
|
| Middle Aged | 43 | 2021 | 9642 | 1.400 |
Why?
|
| Risk Factors | 26 | 2022 | 3414 | 1.370 |
Why?
|
| Stress, Psychological | 6 | 2017 | 541 | 1.320 |
Why?
|
| Haiti | 6 | 2024 | 59 | 1.320 |
Why?
|
| Consumer Product Safety | 4 | 2008 | 10 | 1.270 |
Why?
|
| Social Environment | 2 | 2019 | 186 | 1.240 |
Why?
|
| Substance-Related Disorders | 9 | 2022 | 685 | 1.220 |
Why?
|
| Rural Population | 8 | 2021 | 253 | 1.210 |
Why?
|
| Retrospective Studies | 16 | 2022 | 1961 | 1.210 |
Why?
|
| Public Assistance | 6 | 2010 | 26 | 1.200 |
Why?
|
| Risk-Taking | 13 | 2020 | 435 | 1.160 |
Why?
|
| Minority Groups | 8 | 2024 | 537 | 1.100 |
Why?
|
| Logistic Models | 15 | 2019 | 894 | 1.080 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2019 | 99 | 1.030 |
Why?
|
| Prevalence | 12 | 2021 | 1425 | 1.020 |
Why?
|
| Foodborne Diseases | 3 | 2010 | 22 | 1.020 |
Why?
|
| Socioeconomic Factors | 13 | 2020 | 1003 | 1.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2019 | 790 | 1.020 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 375 | 1.010 |
Why?
|
| Depression | 3 | 2019 | 664 | 0.980 |
Why?
|
| Food Services | 5 | 2010 | 29 | 0.890 |
Why?
|
| Gonorrhea | 2 | 2021 | 31 | 0.880 |
Why?
|
| Social Class | 4 | 2018 | 228 | 0.860 |
Why?
|
| Anti-Retroviral Agents | 4 | 2023 | 139 | 0.830 |
Why?
|
| Professional-Patient Relations | 2 | 2023 | 44 | 0.820 |
Why?
|
| Urban Health | 4 | 2016 | 86 | 0.800 |
Why?
|
| Odds Ratio | 10 | 2018 | 517 | 0.800 |
Why?
|
| Pregnancy | 14 | 2022 | 1503 | 0.800 |
Why?
|
| Pregnant Women | 3 | 2022 | 48 | 0.780 |
Why?
|
| Chlamydia | 1 | 2021 | 42 | 0.780 |
Why?
|
| Unsafe Sex | 5 | 2019 | 161 | 0.770 |
Why?
|
| Cause of Death | 3 | 2016 | 154 | 0.770 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 67 | 0.740 |
Why?
|
| Triage | 1 | 2020 | 27 | 0.740 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 44 | 0.730 |
Why?
|
| Cross-Sectional Studies | 14 | 2024 | 2561 | 0.720 |
Why?
|
| Ambulatory Care Facilities | 3 | 2009 | 61 | 0.710 |
Why?
|
| Asthma | 2 | 2017 | 363 | 0.700 |
Why?
|
| Medication Adherence | 4 | 2023 | 165 | 0.700 |
Why?
|
| Health Services Accessibility | 6 | 2021 | 531 | 0.690 |
Why?
|
| Chlamydia Infections | 2 | 2019 | 196 | 0.690 |
Why?
|
| Parents | 2 | 2019 | 288 | 0.680 |
Why?
|
| Patient Compliance | 1 | 2020 | 202 | 0.660 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 254 | 0.640 |
Why?
|
| Child, Preschool | 12 | 2017 | 1318 | 0.620 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 198 | 0.600 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2017 | 12 | 0.600 |
Why?
|
| Sexual Behavior | 8 | 2020 | 587 | 0.600 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 15 | 0.600 |
Why?
|
| Risk Assessment | 5 | 2016 | 727 | 0.600 |
Why?
|
| Mercury | 1 | 2017 | 35 | 0.590 |
Why?
|
| Infant, Newborn | 9 | 2022 | 871 | 0.590 |
Why?
|
| Sexually Transmitted Diseases | 5 | 2018 | 165 | 0.580 |
Why?
|
| Qualitative Research | 4 | 2023 | 393 | 0.580 |
Why?
|
| Vaccination | 5 | 2024 | 259 | 0.570 |
Why?
|
| Life Change Events | 1 | 2016 | 85 | 0.570 |
Why?
|
| Environmental Exposure | 2 | 2017 | 207 | 0.570 |
Why?
|
| Infant | 11 | 2022 | 1014 | 0.560 |
Why?
|
| Death Certificates | 1 | 2015 | 12 | 0.550 |
Why?
|
| Multilevel Analysis | 4 | 2019 | 16 | 0.530 |
Why?
|
| Substance Abuse, Intravenous | 4 | 2020 | 123 | 0.520 |
Why?
|
| Lead Poisoning | 2 | 2005 | 24 | 0.520 |
Why?
|
| Program Evaluation | 3 | 2020 | 316 | 0.510 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 292 | 0.500 |
Why?
|
| Child | 12 | 2019 | 2875 | 0.470 |
Why?
|
| beta-Lactamases | 3 | 2021 | 33 | 0.440 |
Why?
|
| Sexual Partners | 5 | 2021 | 308 | 0.430 |
Why?
|
| Cuba | 4 | 2019 | 32 | 0.420 |
Why?
|
| HIV | 2 | 2018 | 97 | 0.410 |
Why?
|
| Cross Infection | 3 | 2020 | 38 | 0.410 |
Why?
|
| Public Health Administration | 3 | 2009 | 25 | 0.410 |
Why?
|
| Housing | 3 | 2022 | 54 | 0.400 |
Why?
|
| Cohort Studies | 5 | 2021 | 1422 | 0.400 |
Why?
|
| Neoplasms | 2 | 2019 | 1033 | 0.400 |
Why?
|
| Biomedical Research | 3 | 2021 | 371 | 0.390 |
Why?
|
| Aged | 13 | 2020 | 6448 | 0.380 |
Why?
|
| Longitudinal Studies | 5 | 2019 | 841 | 0.380 |
Why?
|
| Maternal-Child Health Centers | 1 | 2010 | 4 | 0.380 |
Why?
|
| Caribbean Region | 3 | 2021 | 63 | 0.370 |
Why?
|
| Multimedia | 1 | 2010 | 16 | 0.370 |
Why?
|
| Proportional Hazards Models | 4 | 2016 | 423 | 0.360 |
Why?
|
| Age Factors | 5 | 2020 | 1007 | 0.360 |
Why?
|
| Demography | 3 | 2019 | 167 | 0.350 |
Why?
|
| Hepacivirus | 2 | 2007 | 59 | 0.350 |
Why?
|
| Voluntary Programs | 1 | 2009 | 4 | 0.350 |
Why?
|
| Students | 4 | 2018 | 452 | 0.350 |
Why?
|
| Sentinel Surveillance | 1 | 2009 | 20 | 0.350 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 141 | 0.350 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2015 | 219 | 0.340 |
Why?
|
| Awareness | 3 | 2018 | 59 | 0.340 |
Why?
|
| Disease Notification | 1 | 2008 | 5 | 0.330 |
Why?
|
| Health Personnel | 2 | 2021 | 200 | 0.330 |
Why?
|
| Hepatitis C Antibodies | 2 | 2007 | 9 | 0.320 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 31 | 0.320 |
Why?
|
| Risk Reduction Behavior | 3 | 2019 | 121 | 0.320 |
Why?
|
| Hepatitis B Vaccines | 2 | 2007 | 14 | 0.320 |
Why?
|
| Refugees | 2 | 2005 | 14 | 0.320 |
Why?
|
| Survival Rate | 3 | 2014 | 310 | 0.320 |
Why?
|
| Health Policy | 2 | 2021 | 149 | 0.320 |
Why?
|
| Sex Distribution | 3 | 2015 | 212 | 0.310 |
Why?
|
| Health Services Research | 1 | 2008 | 133 | 0.310 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 188 | 0.310 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2006 | 7 | 0.300 |
Why?
|
| Safe Sex | 4 | 2020 | 73 | 0.300 |
Why?
|
| Hepatitis C, Chronic | 1 | 2007 | 39 | 0.300 |
Why?
|
| Syphilis | 1 | 2006 | 27 | 0.290 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 520 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 355 | 0.280 |
Why?
|
| Emigration and Immigration | 2 | 2006 | 72 | 0.270 |
Why?
|
| Vital Statistics | 2 | 2017 | 7 | 0.260 |
Why?
|
| Condoms | 5 | 2019 | 132 | 0.260 |
Why?
|
| Incidence | 6 | 2015 | 882 | 0.260 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 136 | 0.250 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2003 | 11 | 0.240 |
Why?
|
| Hepatitis B virus | 1 | 2003 | 13 | 0.240 |
Why?
|
| Social Support | 2 | 2017 | 356 | 0.240 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 2333 | 0.240 |
Why?
|
| Disclosure | 1 | 2023 | 31 | 0.240 |
Why?
|
| Hepatitis B | 1 | 2003 | 39 | 0.240 |
Why?
|
| Canada | 1 | 2023 | 121 | 0.240 |
Why?
|
| Research Personnel | 2 | 2021 | 133 | 0.230 |
Why?
|
| Latin America | 2 | 2021 | 41 | 0.230 |
Why?
|
| HIV Seropositivity | 2 | 2015 | 182 | 0.220 |
Why?
|
| South America | 2 | 2019 | 16 | 0.210 |
Why?
|
| Population Density | 2 | 2020 | 19 | 0.210 |
Why?
|
| Prediabetic State | 1 | 2022 | 51 | 0.210 |
Why?
|
| Administrative Personnel | 1 | 2021 | 8 | 0.200 |
Why?
|
| Mothers | 2 | 2016 | 164 | 0.200 |
Why?
|
| Mexico | 3 | 2017 | 223 | 0.200 |
Why?
|
| Time Factors | 3 | 2019 | 1681 | 0.200 |
Why?
|
| Intensive Care Units | 1 | 2021 | 57 | 0.200 |
Why?
|
| Career Mobility | 1 | 2021 | 24 | 0.200 |
Why?
|
| Information Dissemination | 1 | 2021 | 58 | 0.200 |
Why?
|
| Premature Birth | 1 | 2022 | 71 | 0.200 |
Why?
|
| Faculty, Medical | 1 | 2021 | 63 | 0.190 |
Why?
|
| Sex Characteristics | 1 | 2022 | 213 | 0.190 |
Why?
|
| Health Surveys | 3 | 2019 | 358 | 0.190 |
Why?
|
| AIDS Serodiagnosis | 1 | 2020 | 25 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 901 | 0.190 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 570 | 0.190 |
Why?
|
| Financing, Government | 1 | 2020 | 18 | 0.180 |
Why?
|
| Comorbidity | 3 | 2019 | 606 | 0.180 |
Why?
|
| Central America | 2 | 2017 | 9 | 0.180 |
Why?
|
| Educational Status | 3 | 2018 | 295 | 0.180 |
Why?
|
| Alcohol Drinking | 3 | 2016 | 490 | 0.180 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 11 | 0.180 |
Why?
|
| Social Control, Informal | 1 | 2019 | 9 | 0.180 |
Why?
|
| Health Promotion | 4 | 2017 | 588 | 0.180 |
Why?
|
| Drug Approval | 1 | 2019 | 6 | 0.180 |
Why?
|
| Drug Evaluation | 1 | 2019 | 9 | 0.180 |
Why?
|
| Liver Diseases | 1 | 2019 | 31 | 0.180 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 22 | 0.180 |
Why?
|
| Tobacco, Smokeless | 1 | 2018 | 18 | 0.170 |
Why?
|
| Drug Users | 1 | 2019 | 42 | 0.170 |
Why?
|
| Pyridones | 1 | 2019 | 40 | 0.170 |
Why?
|
| Health Behavior | 2 | 2022 | 491 | 0.170 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 424 | 0.170 |
Why?
|
| Pyrazoles | 1 | 2019 | 80 | 0.170 |
Why?
|
| Alcohol-Related Disorders | 2 | 2016 | 52 | 0.170 |
Why?
|
| Mass Media | 2 | 2008 | 31 | 0.160 |
Why?
|
| Health Facility Environment | 1 | 2018 | 4 | 0.160 |
Why?
|
| Case Management | 1 | 2018 | 21 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 195 | 0.160 |
Why?
|
| Individuality | 1 | 2018 | 44 | 0.160 |
Why?
|
| Marketing | 1 | 2017 | 38 | 0.160 |
Why?
|
| Developing Countries | 1 | 2018 | 97 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2019 | 159 | 0.150 |
Why?
|
| Child Health Services | 2 | 2008 | 41 | 0.150 |
Why?
|
| Health Services Misuse | 1 | 2017 | 12 | 0.150 |
Why?
|
| Public Health | 1 | 2021 | 348 | 0.150 |
Why?
|
| Spouses | 1 | 2017 | 29 | 0.150 |
Why?
|
| Adult Children | 1 | 2016 | 5 | 0.150 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 55 | 0.140 |
Why?
|
| Puerto Rico | 2 | 2018 | 1352 | 0.140 |
Why?
|
| Behavior Therapy | 1 | 2017 | 145 | 0.140 |
Why?
|
| Child Abuse | 1 | 2016 | 60 | 0.140 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 14 | 0.140 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2015 | 41 | 0.140 |
Why?
|
| Papillomavirus Infections | 2 | 2017 | 316 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2015 | 62 | 0.130 |
Why?
|
| Poverty Areas | 1 | 2015 | 37 | 0.130 |
Why?
|
| Sex Factors | 2 | 2017 | 859 | 0.130 |
Why?
|
| Minority Health | 1 | 2015 | 81 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2014 | 37 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2014 | 57 | 0.120 |
Why?
|
| Confidence Intervals | 2 | 2011 | 151 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2015 | 206 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 465 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2011 | 592 | 0.120 |
Why?
|
| Mexican Americans | 1 | 2015 | 177 | 0.120 |
Why?
|
| Interviews as Topic | 2 | 2021 | 356 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 628 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 213 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 185 | 0.110 |
Why?
|
| Mortality | 2 | 2011 | 150 | 0.110 |
Why?
|
| Hypertension | 2 | 2017 | 770 | 0.110 |
Why?
|
| Exercise | 1 | 2017 | 524 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2013 | 322 | 0.110 |
Why?
|
| Age Distribution | 2 | 2019 | 223 | 0.100 |
Why?
|
| Focus Groups | 2 | 2017 | 307 | 0.100 |
Why?
|
| United States Social Security Administration | 1 | 2011 | 4 | 0.100 |
Why?
|
| Workload | 1 | 2011 | 22 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 187 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2011 | 67 | 0.090 |
Why?
|
| Self Efficacy | 2 | 2022 | 173 | 0.090 |
Why?
|
| Computer-Assisted Instruction | 1 | 2010 | 27 | 0.090 |
Why?
|
| Data Collection | 1 | 2010 | 188 | 0.090 |
Why?
|
| Nutritional Sciences | 1 | 2009 | 21 | 0.090 |
Why?
|
| Food Contamination | 1 | 2010 | 55 | 0.090 |
Why?
|
| Malawi | 2 | 2020 | 9 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2016 | 487 | 0.090 |
Why?
|
| Public Health Informatics | 1 | 2009 | 8 | 0.090 |
Why?
|
| Diarrhea | 1 | 2009 | 84 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2011 | 333 | 0.090 |
Why?
|
| Communication | 2 | 2021 | 170 | 0.090 |
Why?
|
| Louisiana | 2 | 2019 | 39 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2009 | 196 | 0.080 |
Why?
|
| Universities | 2 | 2008 | 363 | 0.080 |
Why?
|
| Education | 1 | 2008 | 48 | 0.080 |
Why?
|
| Program Development | 1 | 2009 | 225 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2008 | 188 | 0.080 |
Why?
|
| Caregivers | 1 | 2010 | 167 | 0.080 |
Why?
|
| Hepatitis A Vaccines | 1 | 2007 | 6 | 0.080 |
Why?
|
| School Health Services | 1 | 2008 | 77 | 0.080 |
Why?
|
| Food Microbiology | 1 | 2007 | 34 | 0.080 |
Why?
|
| Maternal Health Services | 1 | 2006 | 11 | 0.070 |
Why?
|
| Medical Records | 1 | 2006 | 37 | 0.070 |
Why?
|
| Population Dynamics | 1 | 2006 | 29 | 0.070 |
Why?
|
| Blood-Borne Pathogens | 2 | 2003 | 7 | 0.070 |
Why?
|
| Video Recording | 1 | 2006 | 32 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2008 | 528 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 628 | 0.070 |
Why?
|
| Delivery, Obstetric | 1 | 2006 | 38 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2006 | 82 | 0.070 |
Why?
|
| Counseling | 1 | 2007 | 105 | 0.070 |
Why?
|
| Rubella Vaccine | 1 | 2006 | 2 | 0.070 |
Why?
|
| Rubella Syndrome, Congenital | 1 | 2006 | 2 | 0.070 |
Why?
|
| Postnatal Care | 1 | 2006 | 12 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2018 | 429 | 0.070 |
Why?
|
| Community Health Services | 1 | 2006 | 175 | 0.070 |
Why?
|
| Schools | 2 | 2017 | 229 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2022 | 1353 | 0.060 |
Why?
|
| Alcoholism | 1 | 2007 | 220 | 0.060 |
Why?
|
| Disease Outbreaks | 2 | 2003 | 155 | 0.060 |
Why?
|
| Organ Transplantation | 1 | 2003 | 17 | 0.060 |
Why?
|
| Hospital Units | 1 | 2003 | 3 | 0.060 |
Why?
|
| Equipment Contamination | 1 | 2003 | 5 | 0.060 |
Why?
|
| Syringes | 1 | 2003 | 6 | 0.060 |
Why?
|
| Child Welfare | 1 | 2003 | 34 | 0.060 |
Why?
|
| Salmonella Food Poisoning | 1 | 2002 | 2 | 0.060 |
Why?
|
| West Nile Fever | 1 | 2003 | 56 | 0.050 |
Why?
|
| West Nile virus | 1 | 2003 | 65 | 0.050 |
Why?
|
| Salmonella typhi | 1 | 2002 | 33 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2022 | 37 | 0.050 |
Why?
|
| Typhoid Fever | 1 | 2002 | 46 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2003 | 120 | 0.050 |
Why?
|
| Birth Weight | 1 | 2022 | 93 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
| Fruit | 1 | 2002 | 159 | 0.050 |
Why?
|
| Carbapenems | 1 | 2020 | 8 | 0.050 |
Why?
|
| Enterobacteriaceae | 1 | 2020 | 26 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 132 | 0.050 |
Why?
|
| Health Status | 1 | 2003 | 356 | 0.050 |
Why?
|
| Philadelphia | 1 | 2019 | 15 | 0.040 |
Why?
|
| Sample Size | 1 | 2019 | 28 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 86 | 0.040 |
Why?
|
| Psychometrics | 1 | 2021 | 292 | 0.040 |
Why?
|
| Registries | 1 | 2020 | 330 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2019 | 97 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 288 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2017 | 43 | 0.040 |
Why?
|
| Eritrea | 1 | 2017 | 1 | 0.040 |
Why?
|
| Government | 1 | 2017 | 7 | 0.040 |
Why?
|
| Medicine, Traditional | 1 | 2017 | 20 | 0.040 |
Why?
|
| Alabama | 1 | 2017 | 46 | 0.040 |
Why?
|
| Mandatory Programs | 1 | 2016 | 4 | 0.040 |
Why?
|
| Virginia | 1 | 2016 | 9 | 0.040 |
Why?
|
| South Carolina | 1 | 2016 | 19 | 0.040 |
Why?
|
| Tennessee | 1 | 2016 | 59 | 0.040 |
Why?
|
| Random Allocation | 1 | 2016 | 139 | 0.040 |
Why?
|
| Seasons | 1 | 2016 | 112 | 0.040 |
Why?
|
| Physician's Role | 1 | 2016 | 34 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2017 | 76 | 0.040 |
Why?
|
| Women's Health | 1 | 2017 | 135 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1056 | 0.040 |
Why?
|
| Family | 1 | 2017 | 162 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2015 | 18 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 183 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 705 | 0.030 |
Why?
|
| Censuses | 1 | 2013 | 24 | 0.030 |
Why?
|
| Income | 1 | 2013 | 135 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2011 | 17 | 0.030 |
Why?
|
| Risk | 1 | 2011 | 256 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 580 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 435 | 0.020 |
Why?
|
| Workplace | 1 | 2011 | 72 | 0.020 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 6 | 0.020 |
Why?
|
| Hygiene | 1 | 2009 | 14 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 152 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2011 | 228 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 224 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 964 | 0.020 |
Why?
|
| Single Person | 1 | 2007 | 4 | 0.020 |
Why?
|
| Rubella | 1 | 2006 | 13 | 0.020 |
Why?
|
| Blood Donors | 1 | 2003 | 17 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 38 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 2003 | 7 | 0.010 |
Why?
|
| Viremia | 1 | 2003 | 40 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 81 | 0.010 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2003 | 22 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2003 | 30 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2003 | 43 | 0.010 |
Why?
|
| Physical Examination | 1 | 2003 | 40 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2003 | 43 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 52 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 94 | 0.010 |
Why?
|
| Frozen Foods | 1 | 2002 | 1 | 0.010 |
Why?
|
| Honduras | 1 | 2002 | 7 | 0.010 |
Why?
|
| Guatemala | 1 | 2002 | 17 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2002 | 27 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 85 | 0.010 |
Why?
|
| Feces | 1 | 2002 | 110 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2002 | 184 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2003 | 287 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 605 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 252 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 641 | 0.010 |
Why?
|